Advocates help raise awareness in Harrison County for Alzheimer's and Brain Awareness Month
CLARKSBURG, W.Va. (WBOY) — June is Alzheimer's and brain awareness month, and here in West Virginia, more than 38,000 people aged 65 and older have been diagnosed with Alzheimer's or some sort of dementia, according to the Alzheimer's Impact Movement. And as the age of people diagnosed is decreasing, general concern is increasing.
Advocates of the cause are helping raise awareness of Alzheimer's and brain health by speaking with local city councils. These advocates were granted a proclamation on behalf of the Harrison County Commission in its meeting on Wednesday, the Clarksburg City Council on Thursday, and will receive one from the Bridgeport City Council on Friday.
12 News spoke with Bill O'Field, Mission Chairman of the North Central Walk to End Alzheimer's, who spoke with doctors from the WVU Rockefeller Neuroscience Institute on what some of the key signs of dementia and Alzheimer's may look like.
Harrison County commissioners split on future of Sunset Ellis property
'It's normal in the aging process to maybe forget a name or forget where you put your car keys, but then you find them. And maybe later in the day, the seniors say, 'but then I remember that name when I get home. The doctor said that's good.' That's just the normal aging process taking place. But it's when you can't cook for yourself, you don't know how to do your laundry, those are the true signs of Alzheimer's,' said O'Field.
O'Field also mentioned to be wary of weight loss and depression, and to maintain a healthy diet and exercise, as a healthy body can help result in a healthy mind.
The Harrison County Senior Center offers an Alzheimer's support group in its boardroom at 10 a.m. on the second Thursday of each month. You can call 304-623-6795 for more information.
The North Central Walk to End Alzheimer's will also be held on Oct. 5 this year at the Meadowbrook Mall with registration beginning at 1 p.m. and the ceremony beginning at 2 p.m.
For more information about Alzheimer's and local resources, you can call 800-272-3900 or click here.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
10 hours ago
- Yahoo
A woman was told she had Alzheimer's 13 years ago. Now she's walking the width of the U.S. after reversing her illness
Judy Benjamin was only 67 when she was diagnosed with Alzheimer's, the devastating disease her mother and several uncles all suffered from. The symptoms started slowly; a forgotten phone number, trouble reading the newspaper. But Benjamin soon found reason to panic after a brain scan showed damage and amyloid plaque build-up — hallmarks of Alzheimer's, the progressive neurodegenerative disorder that typically affects memory, thinking, and behavior. Now 81, Benjamin is in the midst of an epic cross-country walk to prove to herself, and others, that reversal of Alzheimer's symptoms is possible thanks to a specific, science-backed protocol — and she's living proof. Having started her journey April 5 in San Diego, her hopes to make it to Saint Augustine, Florida, by October 5. She's being accompanied by a support team, and a film crew shooting footage for a documentary. This week she celebrated hitting 1,000 miles. 'I've been really thrilled with the people I've met along the way,' Benjamin told The Independent . 'Everyone knows someone with Alzheimer's and they're very interested in my story because I reversed my cognitive decline by radically changing my life.' Getting to this point took a series of small steps and big ones as Benjamin navigated her diagnosis. Her symptoms started shortly after her own mother died of the disease 20 years after her initial diagnosis. "I was working overseas and started to get really worried because I couldn't remember things — even my own phone number or locker combination," she recalled to Fox News Digital. "I got lost driving, when I'm always really good about direction." Scans of Benjamin's brain showed lots of amyloid plaque — proteins that, when built up on the brain, can result in nerve cell death — and damage to the right and left parietal areas of her brain. Located behind the brain's frontal lobe, the parietal lobe helps with location awareness and processes your sense of touch, according to the Cleveland Clinic. "I knew that it was going downhill really quickly, and I was extremely depressed and distressed about that,' she said. In an attempt to chart a new path forward, Benjamin met with Dr. Dale Bredesen at a friend's urging. Bredesen, an internationally recognized expert in the mechanisms of neurodegenerative diseases and the Chief Science Officer of Apollo Health, had been developing a protocol to reverse the signs and symptoms of Alzheimer's but had yet to test it on a patient. He's long been a believer that Alzheimer's isn't just preventable — it's reversible, too. So, Benjamin seeking treatment at the time Bredesen was looking for a 'patient zero' was kismet. Brededsen recalled Benjamin taking 'copious notes' during her first appointment due to her poor memory. He had Benjamin follow his ReCODE (for 'reversal of cognitive decline') protocol, which included changes to Benjamin's diet and exercise routine, as well as making adjustments to her sleep habits and starting meditation. As Bredesen explained to The Independent about ReCODE: 'The bottom line is that it is a personalized, precision medicine protocol that addresses the drivers specific to each person (so it is based on each person's lab results), and these drivers are in three major groups —energetics (blood flow, oxygenation, etc.), inflammation (from any of many different causes), and toxicity (inorganics, organics, and biotoxins) — and three lesser groups — trophic support (hormones, nutrients, and growth factors), neurotransmitters (such as acetylcholine, which is needed for memory), and stress.' Bredesen noted, too, that despite published documentation of the ways in which cognitive decline can be reversed, the vast majority of people remain unaware that it is often possible. Treatment is also more likely to be effective if started early on. He's documented his research in several books, including The End of Alzheimer's and The Ageless Brain. Together, the pair have worked to maintain her progress. She's become a brain health coach and a yoga instructor, and, as Bredesen described her, 'a survivor of cognitive decline, and a remarkable role model for anyone interested in healthy aging.' 'Very very few people are capable of walking 3000 miles, from coast to coast. But to have someone doing it who is 81 years old, and has reversed her cognitive decline after a diagnosis of early Alzheimer's in 2012, is truly historic,' Bredesen told The Independent. 'She is doing something that I could not do, nor could most of the people I know. She is truly an inspiration.' Still, Benjamin's message is simple — offering the hope that cognitive decline can be prevented and reversed. 'That is really the purpose of my journey,' she told The Independent. 'And also to show that you can be 81 years old and walk all this way one step at a time.'
Yahoo
13 hours ago
- Yahoo
A woman was told she had Alzheimer's 13 years ago. Now she's walking the width of the U.S. after reversing her illness
Judy Benjamin was only 67 when she was diagnosed with Alzheimer's, the devastating disease her mother and several uncles all suffered from. The symptoms started slowly; a forgotten phone number, trouble reading the newspaper. But Benjamin soon found reason to panic after a brain scan showed damage and amyloid plaque build-up — hallmarks of Alzheimer's, the progressive neurodegenerative disorder that typically affects memory, thinking, and behavior. Now 81, Benjamin is in the midst of an epic cross-country walk to prove to herself, and others, that reversal of Alzheimer's symptoms is possible thanks to a specific, science-backed protocol — and she's living proof. Having started her journey April 5 in San Diego, her hopes to make it to Saint Augustine, Florida, by October 5. She's being accompanied by a support team, and a film crew shooting footage for a documentary. This week she celebrated hitting 1,000 miles. 'I've been really thrilled with the people I've met along the way,' Benjamin told The Independent . 'Everyone knows someone with Alzheimer's and they're very interested in my story because I reversed my cognitive decline by radically changing my life.' Getting to this point took a series of small steps and big ones as Benjamin navigated her diagnosis. Her symptoms started shortly after her own mother died of the disease 20 years after her initial diagnosis. "I was working overseas and started to get really worried because I couldn't remember things — even my own phone number or locker combination," she recalled to Fox News Digital. "I got lost driving, when I'm always really good about direction." Scans of Benjamin's brain showed lots of amyloid plaque — proteins that, when built up on the brain, can result in nerve cell death — and damage to the right and left parietal areas of her brain. Located behind the brain's frontal lobe, the parietal lobe helps with location awareness and processes your sense of touch, according to the Cleveland Clinic. "I knew that it was going downhill really quickly, and I was extremely depressed and distressed about that,' she said. In an attempt to chart a new path forward, Benjamin met with Dr. Dale Bredesen at a friend's urging. Bredesen, an internationally recognized expert in the mechanisms of neurodegenerative diseases and the Chief Science Officer of Apollo Health, had been developing a protocol to reverse the signs and symptoms of Alzheimer's but had yet to test it on a patient. He's long been a believer that Alzheimer's isn't just preventable — it's reversible, too. So, Benjamin seeking treatment at the time Bredesen was looking for a 'patient zero' was kismet. Brededsen recalled Benjamin taking 'copious notes' during her first appointment due to her poor memory. He had Benjamin follow his ReCODE (for 'reversal of cognitive decline') protocol, which included changes to Benjamin's diet and exercise routine, as well as making adjustments to her sleep habits and starting meditation. As Bredesen explained to The Independent about ReCODE: 'The bottom line is that it is a personalized, precision medicine protocol that addresses the drivers specific to each person (so it is based on each person's lab results), and these drivers are in three major groups —energetics (blood flow, oxygenation, etc.), inflammation (from any of many different causes), and toxicity (inorganics, organics, and biotoxins) — and three lesser groups — trophic support (hormones, nutrients, and growth factors), neurotransmitters (such as acetylcholine, which is needed for memory), and stress.' Bredesen noted, too, that despite published documentation of the ways in which cognitive decline can be reversed, the vast majority of people remain unaware that it is often possible. Treatment is also more likely to be effective if started early on. He's documented his research in several books, including The End of Alzheimer's and The Ageless Brain. Together, the pair have worked to maintain her progress. She's become a brain health coach and a yoga instructor, and, as Bredesen described her, 'a survivor of cognitive decline, and a remarkable role model for anyone interested in healthy aging.' 'Very very few people are capable of walking 3000 miles, from coast to coast. But to have someone doing it who is 81 years old, and has reversed her cognitive decline after a diagnosis of early Alzheimer's in 2012, is truly historic,' Bredesen told The Independent. 'She is doing something that I could not do, nor could most of the people I know. She is truly an inspiration.' Still, Benjamin's message is simple — offering the hope that cognitive decline can be prevented and reversed. 'That is really the purpose of my journey,' she told The Independent. 'And also to show that you can be 81 years old and walk all this way one step at a time.'
New York Post
a day ago
- New York Post
This common kitchen herb ingredient could help target or slow Alzheimer's
Experts believe they've identified a chemical compound in certain herbs that could help mitigate or prevent Alzheimer's disease — but before anyone makes a run for the spice rack, there are a few catches. In a study published in the journal Antioxidants earlier this year, researchers from the Scripps Research Institute identified a compound called carnosic acid, which is prevalent in rosemary and sage. Advertisement The compound could prove therapeutic for neurodegenerative disorders, including Alzheimer's disease, the experts concluded. Carnosic acid contains 'striking antioxidant [and] anti-inflammatory properties,' the researchers wrote in the findings. Scripps Research postdoctoral associate Piu Banerjee and board-certified neurologist Dr. Stuart Lipton, based in California, spoke with Fox News Digital about the results. 'In this study, we observed that administering this drug to mice that had advanced Alzheimer's-like disease significantly improved the number of neurons, as well as the number of synapses or connections between the brain cells,' the team said. Advertisement 4 Experts believe they've identified a chemical compound, carnosic acid, in certain herbs like rosemary and sage that could help mitigate or prevent Alzheimer's disease. Brent Hofacker – The experts added, 'It also reduced inflammation that is caused by the current anti-amyloid antibody therapies. We also observed an improvement in the learning and memory behavior of the mice that received the drug.' Banerjee and Lipton also noted that carnosic acid is a 'prodrug,' meaning it's inactive at first — but once it enters the body, it's activated by oxidative and inflammatory stress. 'It specifically targets cells undergoing oxidative and inflammatory stress, without affecting the healthy, normal brain cells,' Banerjee said. Advertisement 'This further makes it a safe option for therapeutics.' The experts agreed that carnosic acid could potentially improve the inflammation that generally occurs in most aging brains. There are cautions, however. Advertisement Courtney Kloske, director of scientific engagement for the Chicago-based Alzheimer's Association, told Fox News Digital that studies based on a mouse model of Alzheimer's can be helpful but are not conclusive. 4 Experts say carnosic acid could improve inflammation occurring in most aging brains. LIGHTFIELD STUDIOS – 'Models are important in helping us understand the basic biology of the disease, but we need human studies in representative populations for ideas to be fully validated,' Kloske said. 'Therefore, while these are intriguing findings, more research is needed to understand the impacts and outcomes of these compounds on people living with, or at risk for, Alzheimer's.' Cooking sage and rosemary won't provide the full anti-inflammatory effects, Banerjee and Lipton stressed. 4 'We need human studies in representative populations for ideas to be fully validated,' Courtney Kloske, director of scientific engagement for the Chicago-based Alzheimer's Association, says about the limitations of the information. – 'Critically, one cannot take sufficient herbs safely to produce the same effect as our new drug,' Banerjee said. The study, funded in part by the National Institutes of Health, did have some limitations, the researchers acknowledged. Advertisement Kloske advised that, at this point, 'no one should consume these herbs (or carnosic acid) to prevent or treat Alzheimer's or other cognitive impairment.' 4 According to Scripps Research postdoctoral associate Piu Banerjee and board-certified neurologist Dr. Stuart Lipton, cooking sage and rosemary won't provide the full anti-inflammatory effects. Ganna – Dr. Lee Murray, a neurologist in Jackson, Tennessee, echoed Kloske's concerns. 'Before patients start incorporating rosemary and sage in every dish they eat, we need to remember these studies are pre-clinical,' Murray told Fox News Digital. Advertisement 'Currently, there is insufficient clinical evidence to recommend rosemary and sage as a standard therapy for Alzheimer's dementia.' Murray, however, said the data 'is encouraging' and opens the door to additional pathways for potential therapeutics. Banerjee said she hopes that 'our drug will start human clinical trials soon.' She added, 'If it proves to be effective, it will be a great new drug for those suffering from Alzheimer's … From the results of our animal studies, we are cautiously optimistic for its success in human clinical trials.'
